SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001178913-21-002984
Filing Date
2021-09-13
Accepted
2021-09-13 16:05:55
Documents
5
Effectiveness Date
2021-09-13

Document Format Files

Seq Description Document Type Size
1 S-8 zk2126574.htm S-8 97899
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 9426
3 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 3057
4 EXHIBIT 23.2 exhibit_23-2.htm EX-23.2 3163
5 image00002.jpg GRAPHIC 8148
  Complete submission text file 0001178913-21-002984.txt   126033
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-259489 | Film No.: 211249679
SIC: 2834 Pharmaceutical Preparations